sciencebriefs
8:42in productionCh. 1 · The pig brain origin/ 8:42 · ceiling 15 min
Neuroscience · Life sciences

Brain-derived neurotrophic factor

Yves-Alain Barde

BDNF wasn’t discovered for its function—it was fished out of pig brains and named.

BDNF was isolated from pig brain tissue in 1982 by Yves-Alain Barde and Hans Thoenen, identifying it as a distinct protein.

NeuroscienceLife sciencesThe brainNeuroscienceProtestThe brain across the network →
Chapters & takeaways4
  1. 0:49
    The pig brain origin

    BDNF was isolated from pig brain tissue in 1982.

  2. 2:12
    A new protein, not a copy

    The isolation identified BDNF as a distinct protein—not just another variant of NGF.

  3. 3:45
    What wasn’t measured

    No assay, no receptor, no neuron—just purification and identification.

  4. 4:57
    Where the name comes from

    This is the sole source of the name ‘brain-derived neurotrophic factor’—nothing more, nothing less.

Worth your time?

Yes. Study the whole thing.

3.5/ 5
What works
  • identifies BDNF as a distinct protein
  • pins its origin to pig brain tissue
  • sets the date and authors unambiguously
What does not
  • establish function
  • show human relevance
  • identify receptors or pathways
  • quantify biological activity
Study it if
  • historians of neuroscience
  • molecular biologists tracing protein nomenclature
Skip it if
  • clinicians
  • psychiatrists
  • drug developers
The written brief2 min read

What the work claims

The work claims only that a new, distinct neurotrophic protein—BDNF—was isolated from pig brain tissue.

BDNF, also called abrineurin, is a protein encoded in humans by the BDNF gene. It belongs to the neurotrophin family of growth factors, which are related to the canonical nerve growth factor (NGF) and also include NT-3 and NT-4/NT-5. It was first isolated from a pig brain in 1982 by Yves-Alain Barde and Hans Thoenen.

How it was done

BDNF was isolated from pig brain tissue in 1982.

What holds up

The isolation of a distinct protein from pig brain tissue in 1982 holds up. The naming and biochemical distinction of BDNF as separate from NGF holds up.

What follows comes from the general account of BDNF, not from the 1982 isolation. BDNF activates the TrkB tyrosine kinase receptor, and it also binds the low-affinity nerve growth factor receptor, p75, whose role is less clear. BDNF acts on neurons in the central and peripheral nervous systems that carry TrkB, supporting the survival of existing neurons and encouraging growth and differentiation of new neurons and synapses. In the brain it is active in the hippocampus, cortex and basal forebrain, and it is also expressed in the retina, kidneys, prostate, motor neurons and skeletal muscle, and found in saliva.

What does not

The work does not establish BDNF’s role in learning, memory, depression, or any disease. It does not show activity in humans, mice, or neurons. It does not quantify potency, affinity, or signalling pathways.

Mice born without the ability to make BDNF have developmental defects in the brain and sensory nervous system and usually die soon after birth. That is a finding about the animal as a whole, which the 1982 isolation of the protein does not supply. The same applies to the clinical side: preliminary research has focused on possible links between BDNF and depression, and lower BDNF levels have been found to signify Alzheimer’s disease and major depressive disorders. Clinicians have expressed interest in BDNF as a potential biomarker for tracking disease progression and response to treatment, but the standard measurement relies mainly on serum or plasma sampling by ELISA, which needs laboratory infrastructure and invasive blood collection.

Why it matters beyond the lab

It matters as the first empirical anchor for all later BDNF research—but only as a starting point, not as evidence for any downstream claim about brain function or therapy.

Is it worth your time

Yes—if you need to trace the origin of a named neurotrophic factor in molecular neuroscience. No—if you seek mechanism, function, or human relevance.

Same field · Neuroscience4 of 45
13:00
Ion channelIon channels are pore-forming proteins that let ions cross cell membranes at very high rates without spending metabolic energy, and their electrical behaviour had been studied indirectly for decades before anyone saw their shape. In 1998, Roderick MacKinnon's laboratory solved the X-ray crystal structure of a bacterial potassium channel, KcsA, revealing a selectivity filter of backbone oxygen atoms arranged to mimic the water shell around a potassium ion, letting it pass while excluding the smaller sodium ion. The work, which earned MacKinnon a share of the 2003 Nobel Prize in Chemistry, turned a long-standing theoretical mechanism into a structure that could be looked at directly.
13:00
Rapid eye movement sleepIn 1953 Nathaniel Kleitman and his student Eugene Aserinsky identified rapid eye movement sleep, a phase marked by waking-like brain activity, near-total muscle paralysis and vivid dreaming, verified by repeating the observation on Kleitman's own daughter before publishing. The finding, later extended by researchers including William Dement and Michel Jouvet, established a durable physiological description of a sleep stage occupying about a fifth to a quarter of adult sleep, arriving in repeated cycles through the night. Competing theories about REM sleep's function, memory consolidation, brain development, thermoregulation, remain unresolved, and the discovery's clinical legacy includes REM sleep behaviour disorder, a condition where the usual muscle paralysis fails and sleepers physically act out their dreams.
13:00
Patch clampWorking together at the Max Planck Institute for Biophysical Chemistry in the late 1970s and early 1980s, Erwin Neher and Bert Sakmann developed the patch clamp, a technique built around pressing a fine glass micropipette against a cell membrane and applying suction to form an extremely tight electrical seal, a gigaseal, with resistance in the range of tens to a hundred gigaohms. That seal cut background noise low enough to record the tiny current flowing through a single ion channel, something older methods using sharp inserted microelectrodes had never been precise enough to isolate. The approach can be adapted into several configurations, keeping a cell intact, gaining access to its whole interior, or excising a patch of membrane entirely, each still standard in electrophysiology today. The technique gave neuroscientists a direct, mechanistic view of the ion channel activity behind nerve impulses and became fundamental to modern pharmacology, earning Neher and Sakmann the 1991 Nobel Prize in Physiology or Medicine.
13:00
NeuroplasticityWorking with dense microelectrode mapping in monkeys, Michael Merzenich and colleagues including William Jenkins and Gregg Recanzone showed that the cortical map of a monkey's hand could reorganise substantially following nerve injury and behavioural training, contradicting the long-held assumption that the adult brain's wiring was fixed after early development. Converging evidence followed: phantom limb sensation tied to cortical reorganisation, structural changes in London taxi drivers' hippocampi, and rehabilitation therapies built on the idea that healthy brain regions can partly take over lost function after a stroke. The same discovery, however, later underwrote commercial brain-training products whose specific efficacy claims have been questioned by independent meta-analyses.
Up next in Science

Brownian motion

1827 · 13:00

Pollen grains jittering under a microscope in 1827 sat unexplained for nearly eighty years until Einstein worked out that invisible molecules were bumping them around, turning a small curiosity into decisive proof that atoms are real.

Play nextBack to Neuroscience
13:00